Spots Global Cancer Trial Database for Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)
Official Title: A Phase I, Open-Label Study of the Safety, Tolerability and Pharmacokinetics of GW572016 in Combination With Docetaxel (Taxotere)
Study ID: NCT00148902
Conditions
Study Description
Brief Summary: This is a safety and tolerability study of GW572016 given with docetaxel (TAXOTERE).
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
GSK Investigational Site, Detroit, Michigan, United States
GSK Investigational Site, Nashville, Tennessee, United States
Contact Details
Name: GSK Clinical Trials
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
